The Hallmarks of Aging

The 2013 Lopez-Otin framework identified nine hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Longevity peptides target multiple of these hallmarks simultaneously.

Epithalon and Telomere Biology

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Prof. Vladimir Khavinson. It activates telomerase in human somatic cells. Telomere elongation has been demonstrated in vitro, and extended lifespan has been shown in multiple animal models. Epithalon also regulates melatonin production through the pineal gland.

GHK-Cu and Gene Regulation

GHK-Cu (copper peptide) is a naturally occurring tripeptide found in human plasma. Its plasma concentration declines from ~200 ng/mL at age 20 to ~80 ng/mL at age 60. Loren Pickart’s microarray studies showed that GHK-Cu modulates the expression of 31.2% of the human genome — upregulating genes for tissue repair and antioxidant defense.

MOTS-c: The Mitochondrial Peptide

MOTS-c is encoded within the mitochondrial genome (12S rRNA), not the nuclear genome. It activates AMPK, the master metabolic regulator, and improves insulin sensitivity. Circulating MOTS-c levels decline with age, and supplementation in aging mice restored metabolic function and extended lifespan.

Practical Research Protocols

Epithalon is typically studied in cycles of 10 days on, followed by a 3-6 month rest period. GHK-Cu is used both systemically and topically for skin applications. Combining these peptides with lifestyle interventions such as caloric restriction and exercise may produce synergistic effects on longevity biomarkers.

Frequently Asked Questions

What makes Epithalon unique among longevity peptides? Epithalon is the only well-characterized synthetic peptide studied specifically for telomerase activation in human somatic cells. Research published in PubMed showed that addition of Epithalon to aging human fibroblast cells induced telomere elongation and allowed cells to make 10 extra divisions beyond the normal Hayflick limit. More recently, a 2025 Biogerontology study from Brunel University London confirmed Epithalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. It is also available in convenient oral capsule format for research requiring non-injectable administration.

How does GHK-Cu regulate gene expression? GHK-Cu was found in microarray studies by Loren Pickart to modulate the expression of over 31% of the human genome — upregulating genes associated with tissue repair, antioxidant defense, and collagen synthesis while downregulating genes linked to inflammation and tissue breakdown. This broad gene-regulatory action makes it one of the most comprehensively studied anti-aging peptides in the literature. Research on GHK-Cu’s mechanism of action is indexed across multiple studies on PubMed.

What is MOTS-c and why is it important for longevity research? MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome — specifically the 12S rRNA open reading frame — making it unique among peptides in that its origin is mitochondrial rather than nuclear. Research published in PubMed confirms it acts primarily through the AICAR-AMPK pathway to regulate energy metabolism, insulin sensitivity, and inflammatory responses. Its circulating levels decline with age, and its restoration in aging animal models has demonstrated improvements in metabolic function and longevity markers. A 2025 PMC study confirmed MOTS-c prevents pancreatic islet cell senescence to delay diabetes.

What are the hallmarks of aging that longevity peptides address? The original Lopez-Otin hallmarks of aging framework (PubMed, 2013) identified nine hallmarks: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. The 2023 expanded framework (PubMed) added chronic inflammation, disabled macroautophagy, and dysbiosis. Longevity peptides from the Best Health IQ peptide database target multiple hallmarks simultaneously: Epithalon targets telomere attrition; GHK-Cu addresses epigenetic alterations and tissue repair; MOTS-c addresses mitochondrial dysfunction and deregulated nutrient sensing.

Can longevity peptides be combined into protocols? Yes — and combination protocols are increasingly studied. The GLOW blend combines GHK-Cu with BPC-157 and TB-500 for a multi-peptide regenerative approach. The KLOW blend extends the GLOW stack with KPV for additional anti-inflammatory support. For researchers combining longevity peptides with growth hormone optimization, Sermorelin and the CJC-1295/Ipamorelin blend are commonly researched complements. All protocols are covered in the Best Health IQ protocols section.

Are there oral formats of longevity peptides available? Yes. Epithalon capsule is available in oral format for research requiring non-injectable administration. For NAD+-related longevity research, NAD+ is available in injectable format, and the TUDCA + 5-Amino-1MQ + NAC + PQQ capsule provides a comprehensive oral mitochondrial and liver support complex. Dosing and administration details are available through the peptide calculator.

Where can I access comprehensive profiles for longevity peptides? The Best Health IQ peptide database contains 58+ comprehensive profiles covering mechanisms, clinical data, dosing protocols, and safety information for all major longevity peptides including Epithalon, GHK-Cu, MOTS-c, and NAD+. The protocols section covers cycling frameworks and combination approaches.